Iranians report banking disruptions as cards and POS payments fail

 

Several Iranian bank card services were disrupted on Saturday, with customers reporting failed payments, blocked transfers and POS errors in messages sent to Iran International.

Iranian media reported disruptions affecting cards issued by Bank Melli, Tejarat, Sepah and Saderat. Messages from users also cited problems with Mellat cards and said both online transfers and ATM or card payments were failing.

One shopkeeper said nearly 90% of bank cards had been down for about four hours, leaving customers unable to make purchases.

Another message from Mashhad said banks had been facing disruptions since the morning.

A customer said cards from Bank Melli, Mellat and Tejarat were not working at a shop, while another message said POS devices were showing an “issuer error.”

https://www.iranintl.com/en/liveblog/202606139149

'Pakistan PM says US-Iran peace deal to be signed within 24 hours'

 

Pakistan’s prime minister said on Saturday that the United States and Iran have agreed to a framework for a peace deal to end the months-long conflict in the Middle East, Reuters reported.

Shehbaz Sharif said a final text of the agreement had been reached and that Pakistan was preparing for an electronic signing expected within the next 24 hours.

He added that technical-level talks would follow next week.

https://www.iranintl.com/en/liveblog/202606139149

https://breakingthenews.net/Article/US-says-it-stopped-Iranian-drone-attack-in-Strait-of-Hormuz/66499512

https://www.zerohedge.com/military/flying-beer-cooler-pentagons-next-kamikaze-drone-ushers-era-cheap-mass-produced-airpower

https://www.foxbusiness.com/video/6398242705112

https://breakingthenews.net/Article/Israeli-drones-strike-southern-Lebanon/66499707

Drugmakers will not be exempt from cost cuts, says German health minister

 While legislation proposed by German Health Minister Nina Warken has prompted several large pharmas to reduce investments in the country, she isn't backing down. In an interview with the Funke newspaper group on Friday, Warken said that drugmakers will not be exempt from cost-cutting measures aimed at closing the budget shortfall faced by public health insurance funds. 

"Every sector must play its part in this reform," she was quoted as saying. Warken's proposal would require higher mandatory rebates from drugmakers, implement tighter reimbursement rules, and introduce a system that would allow insurers to group similar patent-protected medicines together and encourage physicians to prescribe the least expensive option.

While Warken acknowledged that the legislation would not help drugmakers bring in additional revenue, she added that "Germany remains an attractive location for the pharmaceutical industry." 

Last week, Handelsblatt reported that Eli Lilly halved a planned €2.3-billion ($2.7 billion) investment in a manufacturing site for its weight loss drugs in Rhineland-Palatinate, while domestic drugmaker Boehringer Ingelheim has scrapped more than €900 million ($1 billion) in planned spending in Germany. Pfizer CEO Albert Bourla detailed his concerns over the proposal in a letter to German Chancellor Friedrich Merz, and pulled out of an international investor conference in the country.

https://firstwordpharma.com/story/7572910